Quick Answer
Imunon, Inc. reported Diluted EPS of $6.83 per share (loss) for fiscal year 2025.
Imunon, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$6.83 | +59.7% |
| 2024 | -$16.94 | -684.3% |
| 2023 | -$2.16 | +57.1% |
| 2022 | -$5.03 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.16 | +69.1% | +46.0% |
| June 30, 2025 | -$2.15 | +71.9% | -667.9% |
| March 31, 2025 | -$0.28 | +46.2% | +92.6% |
| September 30, 2024 | -$3.76 | -916.2% | +50.8% |
| June 30, 2024 | -$7.64 | -1152.5% | -1369.2% |
| March 31, 2024 | -$0.52 | +23.5% | -40.5% |
| September 30, 2023 | -$0.37 | +57.5% | +39.3% |
| June 30, 2023 | -$0.61 | +29.9% | +10.3% |
- Imunon, Inc. showed an increase of +59.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Imunon, Inc.’s diluted eps has declined by 35.8% (from $5.03 per share (loss) to $6.83 per share (loss)).
- The most recent figure is from Imunon, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: